Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels <it>in vitro </it>and <it>in vivo</it>

by Sano Mary, Hyslop Peter, Fraser Paul, Westaway David, Restivo Jessica L, Verges Deborah K, Cirrito John R, Kim Soong H, Steele John W, Bezprozvanny Ilya, Ehrlich Michelle E, Holtzman David M, Gandy Sam
Published 2009-12-01